Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery
NCT07217899Phase 2Recruiting
- Sponsor
- University of Michigan
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of calcium gluconate in uterine atony, postpartum hemorrhage (PPH), sponsored by University of Michigan. Started Oct 2025; status: recruiting.
02
Drugs
calcium gluconate
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07217899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07217899.